Probiotic and enterohemorrhagic Escherichia coli: An effective strategy against a deadly enemy?

References

• Ahmed B, Loos M, Vanrompay D, Cox E. (2014). Oral immunization with Lactococcus lactis-expressing EspB induces protective immune responses against Escherichia coli O157:H7 in a murine model of colonization. Vaccine 32:3909–16.
   PubMed Web of Science ®Google Scholar
• Alsharif G, Ahmad S, Islam MS, et al. (2015). Host attachment and fluid shear are integrated into a mechanical signal regulating virulence in Escherichia coli O157:H7. Proc Natl Acad Sci USA 112:5503–8.
   PubMed Web of Science ®Google Scholar
• Arena MP, Russo P, Capozzi V, et al. (2014). Probiotic abilities of riboflavin-overproducing Lactobacillus strains: a novel promising application of probiotics. Appl Microbiol Biotechnol 98:7569–81.
   PubMed Web of Science ®Google Scholar
• Asahara T, Shimizu K, Nomoto K, et al. (2004). Probiotic bifidobacteria protect mice from lethal infection with Shiga toxin-producing Escherichia coli O157:H7. Infect Immun 72:2240–7.
   PubMed Web of Science ®Google Scholar
• Barnett Foster D. (2013). Modulation of the enterohemorrhagic E. coli virulence program through the human gastrointestinal tract. Virulence 4:315–23.
   PubMed Web of Science ®Google Scholar
• Bauwens A, Betz J, Meisen I, et al. (2013). Facing glycosphingolipid–Shiga toxin interaction: dire straits for endothelial cells of the human vasculature. Cell Mol Life Sci 70:425–57.
   PubMed Web of Science ®Google Scholar
• Bergan J, Dyve Lingelem AB, Simm R, et al. (2012). Shiga toxins. Toxicon 60:1085–107.
   PubMed Web of Science ®Google Scholar
• Berry ED, Wells JE. (2010). Escherichia coli O157:H7: recent advances in research on occurrence, transmission, and control in cattle and the production environment. Adv Food Nutr Res 60:67–117.
   Google Scholar
• Bevilacqua A, Altieri C, Corbo MR, et al. (2010). Characterization of lactic acid bacteria isolated from Italian Bella di Cerignola table olives: selection of potential multifunctional starter cultures. J Food Sci 75:M536–44.
   PubMed Web of Science ®Google Scholar
• Blanquet-Diot S, Denis S, Chalancon S, et al. (2012). Use of artificial digestive systems to investigate the biopharmaceutical factors influencing the survival of probiotic yeast during gastrointestinal transit in humans. Pharm Res 29:1444–53.
   PubMed Web of Science ®Google Scholar
• Branchu P, Matrat S, Vareille M, et al. (2014). NsrR, GadE, and GadX interplay in repressing expression of the Escherichia coli O157:H7 LEE pathogenicity island in response to nitric oxide. PLoS Pathog 10:e1003874.
   PubMed Web of Science ®Google Scholar
• Bryan A, Youngster I, McAdam AJ. (2015). Shiga toxin producing Escherichia coli. Clin Lab Med 35:247–72.
   PubMed Web of Science ®Google Scholar
• Calderón O, Padilla C, Chaves C, et al. (2007). [Evaluation of the effect of Lactobacillus rhamnosus probiotic culture added to yogurt over Staphylococcus aureus, Escherichia coli O157:H7, Listeria monocytogenes and Salmonella enteritidis populations]. Arch Latinoam Nutr 57:51–5.
   PubMed Web of Science ®Google Scholar
• Carey CM, Kostrzynska M, Ojha S, Thompson S. (2008). The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7. J Microbiol Methods 73:125–32.
   PubMed Web of Science ®Google Scholar
• Chen X, Xu J, Shuai J, et al. (2007). The S-layer proteins of Lactobacillus crispatus strain ZJ001 is responsible for competitive exclusion against Escherichia coli O157:H7 and Salmonella typhimurium. Int J Food Microbiol 115:307–12.
   PubMed Web of Science ®Google Scholar
• Chong Y, Fitzhenry R, Heuschkel R, et al. (2007). Human intestinal tissue tropism in Escherichia coli O157: H7–initial colonization of terminal ileum and Peyer’s patches and minimal colonic adhesion ex vivo. Microbiol (Read Engl) 153:794–802.
   PubMed Web of Science ®Google Scholar
• Connolly JPR, Finlay BB, Roe AJ. (2015). From ingestion to colonization: the influence of the host environment on regulation of the LEE encoded type III secretion system in enterohaemorrhagic Escherichia coli. Front Microbiol 6:568. doi:10.3389/fmicb.2015.00568.
   PubMed Web of Science ®Google Scholar
• Curtis MM, Hu Z, Klimko C, et al. (2014). The gut commensal Bacteroides thetaiotaomicron exacerbates enteric infection through modification of the metabolic landscape. Cell Host Microbe 16:759–69.
   PubMed Web of Science ®Google Scholar
• Dahan S, Dalmasso G, Imbert V, et al. (2003). Saccharomyces boulardii interferes with enterohemorrhagic Escherichia coli-induced signaling pathways in T84 cells. Infect Immun 71:766–73.
   PubMed Web of Science ®Google Scholar
• Dalmasso G, Loubat A, Dahan S, et al. (2006). Saccharomyces boulardii prevents TNF-alpha-induced apoptosis in EHEC-infected T84 cells. Res Microbiol 157:456–65.
   PubMed Web of Science ®Google Scholar
• de Sablet T, Chassard C, Bernalier-Donadille A, et al. (2009). Human microbiota-secreted factors inhibit Shiga toxin synthesis by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 77:783–90.
   PubMed Web of Science ®Google Scholar
• Didari T, Solki S, Mozaffari S, et al. (2014). A systematic review of the safety of probiotics. Expert Opin Drug Saf 13:227–39.
   PubMed Web of Science ®Google Scholar
• Dunière L, Gleizal A, Chaucheyras-Durand F, et al. (2011). Fate of Escherichia coli O26 in corn silage experimentally contaminated at ensiling, at silo opening, or after aerobic exposure, and protective effect of various bacterial inoculants. Appl Environ Microbiol 77:8696–704.
   PubMed Web of Science ®Google Scholar
• Duniere L, Jin L, Smiley B, et al. (2015). Impact of adding Saccharomyces strains on fermentation, aerobic stability, nutritive value, and select lactobacilli populations in corn silage. J Anim Sci 93:2322–35.
   PubMed Web of Science ®Google Scholar
• Eaton KA, Honkala A, Auchtung TA, Britton RA. (2011). Probiotic Lactobacillus reuteri ameliorates disease due to enterohemorrhagic Escherichia coli in germfree mice. Infect Immun 79:185–91.
   PubMed Web of Science ®Google Scholar
• Etienne-Mesmin L, Chassaing B, Sauvanet P, et al. (2011a). Interactions with M Cells and Macrophages as key steps in the pathogenesis of enterohemorrhagic Escherichia coli infections. PLoS One 6:e23594.
   PubMed Web of Science ®Google Scholar
• Etienne-Mesmin L, Livrelli V, Privat M, et al. (2011b). Effect of a new probiotic Saccharomyces cerevisiae strain on survival of Escherichia coli O157:H7 in a dynamic gastrointestinal model. Appl Environ Microbiol 77:1127–31.
   PubMed Web of Science ®Google Scholar
• FAO/WHO. (2002). Report of a joint FAO/WHO working group on drafture Organization of the United Nations and World Health Organization. London, Ontario, Canada.
   Google Scholar
• Foligné B, Daniel C, Pot B. (2013). Probiotics from research to market: the possibilities, risks and challenges. Curr Opin Microbiol 16:284–92.
   PubMed Web of Science ®Google Scholar
• Forano E, Chaucheyras-Durand F, Bertin Y, Martin C. (2013). [EHEC carriage in ruminants and probiotic effects]. Biol Aujourdhui, 207:261–7.
   PubMedGoogle Scholar
• Frank C, Werber D, Cramer JP, et al. HUS Investigation Team. (2011). Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany. N Engl J Med 365:1771–80.
   PubMed Web of Science ®Google Scholar
• Fukuda S, Toh H, Hase K, et al. (2011). Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469:543–7.
   PubMed Web of Science ®Google Scholar
• Fukuda S, Toh H, Taylor TD, et al. (2012). Acetate-producing bifidobacteria protect the host from enteropathogenic infection via carbohydrate transporters. Gut Microbes 3:449–54.
   PubMed Web of Science ®Google Scholar
• Gagnon M, Kheadr EE, Dabour N, et al. (2006). Effect of Bifidobacterium thermacidophilum probiotic feeding on enterohemorrhagic Escherichia coli O157:H7 infection in BALB/c mice. Int J Food Microbiol 111:26–33.
   PubMed Web of Science ®Google Scholar
• Garcia-Angulo VA, Kalita A, Torres AG. (2013). Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection. Vaccine 31:3229–35.
   PubMed Web of Science ®Google Scholar
• Gedek BR. (1999). Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 42:261–4.
   PubMed Web of Science ®Google Scholar
• Goldwater PN, Bettelheim KA. (2012). Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS). BMC Med 10:12.
   PubMed Web of Science ®Google Scholar
• Guerra A, Etienne-Mesmin L, Livrelli V, et al. (2012). Relevance and challenges in modeling human gastric and small intestinal digestion. Trends Biotechnol 30:591–600.
   PubMed Web of Science ®Google Scholar
• Gu J, Ning Y, Wang H, et al. (2011). Vaccination of attenuated EIS-producing Salmonella induces protective immunity against enterohemorrhagic Escherichia coli in mice. Vaccine 29:7395–403.
   PubMed Web of Science ®Google Scholar
• Hemarajata P, Versalovic J. (2013). Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therap Adv Gastroenterol 6:39–51.
   PubMed Web of Science ®Google Scholar
• Hill C, Guarner F, Reid G, et al. (2014). Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506–14.
   PubMed Web of Science ®Google Scholar
• Hirano J, Yoshida T, Sugiyama T, et al. (2003). The effect of Lactobacillus rhamnosus on enterohemorrhagic Escherichia coli infection of human intestinal cells in vitro. Microbiol Immunol 47:405–9.
   PubMed Web of Science ®Google Scholar
• Hoffmann DE. (2013). Health claim regulation of probiotics in the USA and the EU: is there a middle way? Benef Microbes 4:109–15.
   PubMed Web of Science ®Google Scholar
• Hugo AA, Kakisu E, De Antoni GL, Pérez PF. (2008). Lactobacilli antagonize biological effects of enterohaemorrhagic Escherichia coli in vitro. Lett Appl Microbiol 46:613–19.
   PubMed Web of Science ®Google Scholar
• Iversen H, Lindbäck T, L’Abée-Lund TM, et al. (2015). The gut bacterium Bacteroides thetaiotaomicron influences the virulence potential of the enterohemorrhagic Escherichia coli O103:H25. PLoS One, 10:e0118140.
   PubMed Web of Science ®Google Scholar
• Johnson-Henry KC, Donato KA, Shen-Tu G, et al. (2008). Lactobacillus rhamnosus strain GG prevents enterohemorrhagic Escherichia coli O157:H7-induced changes in epithelial barrier function. Infect Immun 76:1340–8.
   PubMed Web of Science ®Google Scholar
• Karpman D, Ståhl AL. (2014). Enterohemorrhagic Escherichia coli pathogenesis and the host response. Microbiol Spectr 2. [Epub ahead of print]. doi:10.1128/microbiolspec.EHEC-0009-2013.
   PubMedGoogle Scholar
• Keir LS. (2015). Shiga toxin associated hemolytic uremic syndrome. Hematol Oncol Clin North Am 29:525–39.
   PubMed Web of Science ®Google Scholar
• Kimmitt PT, Harwood CR, Barer MR. (2000). Toxin gene expression by shiga toxin-producing Escherichia coli: the role of antibiotics and the bacterial SOS response. Emerging Infect Dis 6:458–65.
   PubMed Web of Science ®Google Scholar
• Kim SH, Yang SJ, Koo HC, et al. (2001). Inhibitory activity of Bifidobacterium longum HY8001 against vero cytotoxin of Escherichia coli O157:H7. J Food Prot 64:1667–73.
   PubMed Web of Science ®Google Scholar
• Kim Y, Kim SH, Whang KY, et al. (2008). Inhibition of Escherichia coli O157:H7 attachment by interactions between lactic acid bacteria and intestinal epithelial cells. J Microbiol Biotechnol 18:1278–85.
   PubMed Web of Science ®Google Scholar
• Kim Y, Oh S, Kim SH. (2009). Released exopolysaccharide (r-EPS) produced from probiotic bacteria reduce biofilm formation of enterohemorrhagic Escherichia coli O157:H7. Biochem Biophys Res Commun 379:324–9.
   PubMed Web of Science ®Google Scholar
• Lapeyraque AL, Malina M, Fremeaux-Bacchi V, et al. (2011). Eculizumab in severe Shiga-toxin-associated HUS. N Engl J Med 364:2561–3.
   PubMed Web of Science ®Google Scholar
• Le Bihan G, Jubelin G, Garneau P, et al. (2015). Transcriptome analysis of Escherichia coli O157:H7 grown in vitro in the sterile-filtrated cecal content of human gut microbiota associated rats reveals an adaptive expression of metabolic and virulence genes. Microbes Infect Inst Pasteur 17:23–33.
   PubMed Web of Science ®Google Scholar
• Lewis SB, Cook V, Tighe R, Schüller S. (2015). Enterohemorrhagic Escherichia coli colonization of human colonic epithelium in vitro and ex vivo. Infect Immun 83:942–9. doi:10.1128/IAI.02928-14.
   PubMed Web of Science ®Google Scholar
• MacConnachie AA, Todd WTA. (2004). Potential therapeutic agents for the prevention and treatment of hemolytic uremic syndrome in shiga toxin producing Escherichia coli infection. Curr Opin Infect Dis 17:479–82.
   PubMed Web of Science ®Google Scholar
• Mack DR, Michail S, Wei S, et al. (1999). Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am J Physiol 276:G941–50.
   PubMed Web of Science ®Google Scholar
• Majowicz SE, Scallan E, Jones-Bitton A, et al. (2014). Global incidence of human Shiga toxin–producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis. Foodborne Pathog Dis 11:447–55.
   PubMed Web of Science ®Google Scholar
• Marzorati M, Vanhoecke B, De Ryck T, et al. (2014). The HMITM module: a new tool to study the host-microbiota interaction in the human gastrointestinal tract in vitro. BMC Microbiol 14:133.
   PubMed Web of Science ®Google Scholar
• McFarland LV. (2015). From yaks to yogurt: the history, development, and current use of probiotics. Clin Infect Dis 60:S85–S90.
   PubMed Web of Science ®Google Scholar
• Medellin-Peña MJ, Griffiths MW. (2009). Effect of molecules secreted by Lactobacillus acidophilus strain La-5 on Escherichia coli O157:H7 colonization. Appl Environ Microbiol 75:1165–72.
   PubMed Web of Science ®Google Scholar
• Medellin-Peña MJ, Wang H, Johnson R, et al. (2007). Probiotics affect virulence-related gene expression in Escherichia coli O157:H7. Appl Environ Microbiol 73:4259–67.
   PubMed Web of Science ®Google Scholar
• Mellies JL, Thomas K, Turvey M, et al. (2012). Zinc-induced envelope stress diminishes type III secretion in enteropathogenic Escherichia coli. BMC Microbiol 12:123.
   PubMed Web of Science ®Google Scholar
• Minekus M, Marteau P, Havenaar R, Huis in ’T Veld JHJ. (1995). A multicompartmental dynamic computer-controlled model simulating the stomach and small intestine. ATLA Altern Lab Anim 23:197–209.
   Web of Science ®Google Scholar
• Minelli EB, Benini A. (2008). Relationship between number of bacteria and their probiotic effects. Microb Ecol Health Dis 20:180–3.
   Google Scholar
• Mohsin M, Guenther S, Schierack P, et al. (2015). Probiotic Escherichia coli Nissle 1917 reduces growth, Shiga toxin expression, release and thus cytotoxicity of enterohemorrhagic Escherichia coli. Int J Med Microbiol 305:20–6.
   PubMed Web of Science ®Google Scholar
• Molly K, Vande Woestyne M, Verstraete W. (1993). Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem. Appl Microbiol Biotechnol 39:254–8.
   PubMed Web of Science ®Google Scholar
• Nakanishi N, Tashiro K, Kuhara S, et al. (2009). Regulation of virulence by butyrate sensing in enterohaemorrhagic Escherichia coli. Microbiology (Reading, Engl.) 155:521–30.
   PubMed Web of Science ®Google Scholar
• Ogawa M, Shimizu K, Nomoto K, et al. (2001a). Protective effect of Lactobacillus casei strain Shirota on Shiga toxin-producing Escherichia coli O157:H7 infection in infant rabbits. Infect Immun 69:1101–8.
   PubMed Web of Science ®Google Scholar
• Ogawa M, Shimizu K, Nomoto K, et al. (2001b). Inhibition of in vitro growth of Shiga toxin-producing Escherichia coli O157:H7 by probiotic Lactobacillus strains due to production of lactic acid. Int J Food Microbiol 68:135–40.
   PubMed Web of Science ®Google Scholar
• Pacheco AR, Curtis MM, Ritchie JM, et al. (2012). Fucose sensing regulates bacterial intestinal colonization. Nature 492:113–17.
   PubMed Web of Science ®Google Scholar
• Pacheco AR, Sperandio V. (2012). Shiga toxin in enterohemorrhagic E. coli: regulation and novel anti-virulence strategies. Front Cell Infect Microbiol 2. [Epub ahead of print]. doi:10.3389/fcimb.2012.00081.
   PubMed Web of Science ®Google Scholar
• Park H, Yeo S, Ji Y, et al. (2014). Autoinducer-2 associated inhibition by Lactobacillus sakei NR28 reduces virulence of enterohaemorrhagic Escherichia coli O157:H7. Food Control 45:62–9.
   Web of Science ®Google Scholar
• Paton AW, Chen AY, Wang H, et al. (2015). Protection against Shiga toxigenic Escherichia coli by non-GMO receptor-mimic bacterial ghosts. Infect Immun 83:3526–33.
   PubMed Web of Science ®Google Scholar
• Paton AW, Morona R, Paton JC. (2000). A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans. Nat Med 6:265–70.
   PubMed Web of Science ®Google Scholar
• Payne AN, Zihler A, Chassard C, Lacroix C. (2012). Advances and perspectives in in vitro human gut fermentation modeling. Trends Biotechnol 30:17–25.
   PubMed Web of Science ®Google Scholar
• Pearson JS, Hartland EL. (2014). The inflammatory response during enterohemorrhagic Escherichia coli infection. Microbiol Spectr 2. [Epub ahead of print]. doi:10.1128/microbiolspec.EHEC-0012-2013.
   PubMedGoogle Scholar
• Pedroso AF, Adesogan AT, Queiroz OCM, Williams SK. (2010). Control of Escherichia coli O157:H7 in corn silage with or without various inoculants: efficacy and mode of action. J Dairy Sci 93:1098–104.
   PubMed Web of Science ®Google Scholar
• Persad AK, LeJeune JT. (2014). Animal reservoirs of Shiga toxin-producing Escherichia coli. Microbiol Spectr 2. [Epub ahead of print]. doi:10.1128/microbiolspec.EHEC-0027-2014.
   PubMedGoogle Scholar
• Phillips AD, Navabpour S, Hicks S, et al. (2000). Enterohaemorrhagic Escherichia coli O157:H7 target Peyer’s patches in humans and cause attaching/effacing lesions in both human and bovine intestine. Gut 47:377–81.
   PubMed Web of Science ®Google Scholar
• Pifer R, Sperandio V. (2014). The Interplay between the microbiota and enterohemorrhagic Escherichia coli. Microbiol Spectr 2. [Epub ahead of print]. doi:10.1128/microbiolspec.EHEC-0015-2013.
   PubMedGoogle Scholar
• Preidis GA, Hill C, Guerrant RL, et al. (2011). Probiotics, enteric and diarrheal diseases, and global health. Gastroenterology 140:8–14.
   PubMed Web of Science ®Google Scholar
• Putaala H, Salusjärvi T, Nordström M, et al. (2008). Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression. Res Microbiol 159:692–8.
   PubMed Web of Science ®Google Scholar
• Rasko DA, Moreira CG, Li DR, et al. (2008). Targeting QseC signaling and virulence for antibiotic development. Science 321:1078–80.
   PubMed Web of Science ®Google Scholar
• Rasko DA, Sperandio V. (2010). Anti-virulence strategies to combat bacteria-mediated disease. Nat Rev Drug Discov 9:117–28.
   PubMed Web of Science ®Google Scholar
• Reading NC, Torres AG, Kendall MM, et al. (2007). A novel two-component signaling system that activates transcription of an enterohemorrhagic Escherichia coli effector involved in remodeling of host actin. J Bacteriol 189:2468–76.
   PubMed Web of Science ®Google Scholar
• Reissbrodt R, Hammes WP, dal Bello F, et al. (2009). Inhibition of growth of Shiga toxin-producing Escherichia coli by nonpathogenic Escherichia coli. FEMS Microbiol Lett 290:62–9.
   PubMed Web of Science ®Google Scholar
• Ritchie JM. (2014). Animal models of enterohemorrhagic Escherichia coli infection. Microbiol Spectr 2. [Epub ahead of print]. doi:10.1128/microbiolspec.EHEC-0022-2013.
   PubMedGoogle Scholar
• Ruiz-Moyano S, Martín A, Benito MJ, et al. (2009). Safety and functional aspects of preselected enterococci for probiotic use in Iberian dry-fermented sausages. J Food Sci 74:M398–404.
   PubMed Web of Science ®Google Scholar
• Rund SA, Rohde H, Sonnenborn U, Oelschlaeger TA. (2013). Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7. Int J Med Microbiol, 303:1–8.
   PubMed Web of Science ®Google Scholar
• Russo P, de Chiara MLV, Vernile A, et al. (2014). Fresh-cut pineapple as a new carrier of probiotic lactic acid bacteria. BioMed Res Int 2014. [Epub ahead of print]. doi:10.1155/2014/309183.
   Web of Science ®Google Scholar
• Salminen S, Wright AV. (2004). Lactic acid bacteria: microbiological and functional aspects. 3rd ed. Boca Raton (FL): CRC Press.
   Google Scholar
• Sanders ME, Akkermans LMA, Haller D, et al. (2010). Safety assessment of probiotics for human use. Gut Microbes 1:164–85.
   PubMed Web of Science ®Google Scholar
• Schüller S. (2011). Shiga toxin interaction with human intestinal epithelium. Toxins 3:626–39.
   PubMed Web of Science ®Google Scholar
• Sherman PM, Johnson-Henry KC, Yeung HP, et al. (2005). Probiotics reduce enterohemorrhagic Escherichia coli O157:H7- and enteropathogenic E. coli O127:H6-induced changes in polarized T84 epithelial cell monolayers by reducing bacterial adhesion and cytoskeletal rearrangements. Infect Immun 73:5183–8.
   PubMed Web of Science ®Google Scholar
• Shu Q, Gill HS. (2002). Immune protection mediated by the probiotic Lactobacillus rhamnosus HN001 (DR20) against Escherichia coli O157:H7 infection in mice. FEMS Immunol Med Microbiol 34:59–64.
   PubMed Web of Science ®Google Scholar
• Siegler RL, Obrig TG, Pysher TJ, et al. (2003). Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome. Pediatr Nephrol (Berl Ger) 18:92–6.
   PubMed Web of Science ®Google Scholar
• Smith JL, Fratamico PM, Gunther NWT, et al. (2014). Shiga toxin-producing Escherichia coli. Adv Appl Microbiol 86:145–97.
   PubMed Web of Science ®Google Scholar
• Snydman DR. (2008). The safety of probiotics. Clin Infect Dis 46:S104–11.
   PubMed Web of Science ®Google Scholar
• Sperandio V, Torres AG, Jarvis B, et al. (2003). Bacteria-host communication: the language of hormones. Proc Natl Acad Sci USA 100:8951–6.
   PubMed Web of Science ®Google Scholar
• Spinler JK, Taweechotipatr M, Rognerud CL, et al. (2008). Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. Anaerobe 14:166–71.
   PubMed Web of Science ®Google Scholar
• Stevens MP, Frankel GM. (2014). The locus of enterocyte effacement and associated virulence factors of enterohemorrhagic Escherichia coli. Microbiol Spectr 2. [Epub ahead of print]. doi:10.1128/microbiolspec.EHEC-0007-2013.
   PubMedGoogle Scholar
• Stöber H, Maier E, Schmidt H. (2010). Protective effects of Lactobacilli, Bifidobacteria and Staphylococci on the infection of cultured HT29 cells with different enterohemorrhagic Escherichia coli serotypes are strain-specific. Int J Food Microbiol 144:133–40.
   PubMed Web of Science ®Google Scholar
• Szu SC, Ahmed A. (2014). Clinical studies of Escherichia coli O157:H7 conjugate vaccines in adults and young children. Microbiol Spectr 2. [Epub ahead of print]. doi: 10.1128/microbiolspec.EHEC-0016-2013.
   Google Scholar
• Tahamtan Y, Kargar M, Namdar N, et al. (2011). Probiotic inhibits the cytopathic effect induced by Escherichia coli O157:H7 in Vero cell line model. Lett Appl Microbiol 52:527–31.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Taguchi H, Yamaguchi H, et al. (2004). The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice. FEMS Immunol Med Microbiol 41:219–26.
   PubMedGoogle Scholar
• Thévenot J, Cordonnier C, Rougeron A, et al. (2015). Enterohemorrhagic Escherichia coli infection has donor-dependent effect on human gut microbiota and may be antagonized by probiotic yeast during interaction with Peyer’s patches. Appl Microbiol Biotechnol 99:9097–110.
   PubMed Web of Science ®Google Scholar
• Thévenot J, Etienne-Mesmin L, Denis S, et al. (2013). Enterohemorrhagic Escherichia coli O157:H7 survival in an in vitro model of the human large intestine and interactions with probiotic yeasts and resident microbiota. Appl Environ Microbiol 79:1058–64.
   PubMed Web of Science ®Google Scholar
• Thomas DE, Elliott EJ. (2013). Interventions for preventing diarrhea-associated hemolytic uremic syndrome: systematic review. BMC Public Health 13:799.
   PubMed Web of Science ®Google Scholar
• Tobe T, Nakanishi N, Sugimoto N. (2011). Activation of motility by sensing short-chain fatty acids via two steps in a flagellar gene regulatory cascade in enterohemorrhagic Escherichia coli. Infect Immun 79:1016–24.
   PubMed Web of Science ®Google Scholar
• McWilliams BD, Torres AG. (2014). Enterohemorrhagic Escherichia coli adhesins. Microbiol Spectr 2. [Epub ahead of print]. doi: 10.1128/microbiolspec.EHEC-0003-2013.
   Google Scholar
• Trachtman H, Cnaan A, Christen E, et al. Investigators of the HUS-SYNSORB Pk Multicenter Clinical Trial. (2003). Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: a randomized controlled trial. JAMA 290:1337–44.
   PubMed Web of Science ®Google Scholar
• Tran SL, Billoud L, Lewis SB, et al. (2014). Shiga toxin production and translocation during microaerobic human colonic infection with Shiga toxin-producing E. coli O157:H7 and O104:H4. Cell Microbiol 16:1255–66.
   PubMed Web of Science ®Google Scholar
• Tsai YT, Cheng PC, Pan TM. (2010). Immunomodulating activity of Lactobacillus paracasei subsp. paracasei NTU 101 in enterohemorrhagic Escherichia coli O157H7-infected mice. J Agric Food Chem 58:11265–72.
   PubMed Web of Science ®Google Scholar
• Turková K, Mavrič A, Narat M, et al. (2013). Evaluation of Lactobacillus strains for selected probiotic properties. Folia Microbiol (Praha) 58:261–7.
   PubMed Web of Science ®Google Scholar
• Varankovich NV, Nickerson MT, Korber DR. (2015). Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases. Front Microbiol 6:685.
   PubMed Web of Science ®Google Scholar
• Venugopalan V, Shriner KA, Wong-Beringer A. (2010). Regulatory oversight and safety of probiotic use. Emerging Infect Dis 16:1661–5.
   PubMed Web of Science ®Google Scholar
• Walters M, Sperandio V. (2006). Quorum sensing in Escherichia coli and Salmonella. Int J Med Microbiol 296:125–31.
   PubMed Web of Science ®Google Scholar
• Yang B, Feng L, Wang F, Wang L. (2015). Enterohemorrhagic Escherichia coli senses low biotin status in the large intestine for colonization and infection. Nat Commun 6:6592.
   PubMed Web of Science ®Google Scholar
• Yoshimura K, Matsui T, Itoh K. (2010). Prevention of Escherichia coli O157:H7 infection in gnotobiotic mice associated with Bifidobacterium strains. Antonie Van Leeuwenhoek 97:107–17.
   PubMed Web of Science ®Google Scholar
• Zhao B, Houry WA. (2010). Acid stress response in enteropathogenic gammaproteobacteria: an aptitude for survival. Biochem Cell Biol Biochim Biol Cell 88:301–14.
   PubMed Web of Science ®Google Scholar